Table 1.
Demographic information on the case series cohort
| London (n=56) | Birmingham (n=35) | Manchester (n=28) | Total (n=119) | |
| Age at presentation, years | 22 (14–37) | 22 (16–39) | 22.5 (17–32) | 22 (14–39) |
| Sex | ||||
| Male | 37 (66.1%) | 29 (82.9%) | 23 (82.1%) | 89 (74.8%) |
| Female | 19 (33.9%) | 6 (17.1%) | 5 (17.9%) | 30 (25.2%) |
| Ethnicity | ||||
| Black | 3 (5.4%) | 3 (8.6%) | 3 (10.7%) | 9 (7.6%) |
| Asian or Asian British | 41 (73.2%) | 19 (54.3%) | 8 (28.6%) | 68 (57.1%) |
| White | 6 (10.7%) | 12 (34.3%) | 5 (17.9%) | 23 (19.3%) |
| Other including mixed | 4 (7.1%) | 1 (2.8%) | 2 (7.1%) | 7 (5.9%) |
| Unknown | 2 (3.6%) | 0 (0.0%) | 10 (35.7%) | 12 (10.1%) |
| Documented smoker | ||||
| Yes | 38 (67.9%) | 13 (37.1%) | 7 (25.0%) | 58 (48.7%) |
| No | 18 (32.1%) | 22 (62.9%) | 21 (75.0%) | 61 (51.3%) |
| Documented alcohol consumption | ||||
| Yes | 30 (53.6%) | 8 (22.9%) | 5 (17.9%) | 43 (36.1%) |
| No | 26 (46.4%) | 27 (77.1%) | 23 (82.1%) | 76 (63.9%) |
| Excessive consumption | 10 (17.9%) | 3 (8.6%) | 0 (0.0%) | 13 (10.9%) |
| Other recreational drugs documented | ||||
| Yes | 21 (37.5%) | 8 (22.9%) | 8 (28.6%) | 37 (31.1%) |
| No | 35 (62.5%) | 27 (77.1%) | 20 (71.4%) | 82 (68.9%) |
| Documented employment or education | ||||
| Yes | 26 (46.4%) | 15 (42.9%) | 8 (28.6%) | 49 (41.2%) |
| No | 30 (53.6%) | 20 (57.1%) | 20 (71.4%) | 70 (58.8%) |
| Documented admission as an inpatient | ||||
| Yes | 20 (35.7%) | 32 (91.4%) | 18 (64.3%) | 70 (58.8%) |
| No | 36 (64.3%) | 3 (8.6%) | 10 (35.7%) | 49 (41.2%) |
| B12 before presentation | ||||
| Documented | 8 (14.3%) | 0 (0.0%) | 5 (82.1%) | 13 (10.9%) |
| Not documented | 48 (85.7%) | 35 (100.0%) | 23 (17.9%) | 106 (89.1%) |
119 patients were included in the case series. The information documented and not documented in electronic records is described. Where relevant, percentages of that value of the total for that column are given in parentheses. Median age and total age range are indicated, as the cohort demonstrated skew on this parameter.